Health In Tech FY2024 revenue $19.5M (+1.8%); adj. EBITDA falls to $2.3M from $4.8M; leadership reshuffled

Health In Tech, Inc.

Full-year 2024 revenue $19.5M (+1.8% YoY); income from continuing ops $0.7M vs $2.5M in 2023.
Q4 2024 revenue $4.9M vs $5.2M; net loss from continuing ops ($0.1M) vs income $1.0M; adjusted EBITDA $0.5M vs $1.0M.
Cash $7.8M at Dec 31, 2024 (up from $2.4M); total liabilities $2.6M (down from $5.4M).
Unaudited Jan-Feb 2025 revenue ~$5.7M, >50% YoY growth, exceeding entire Q1 2024.
Leadership changes: Chris Kurtenbach promoted to COO; Dustin Plantholt named Chief Growth Officer; Jenni Guerrica CISO; Jonathan Del Lockett becomes Chief Strategy Officer.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.